Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0011849 (
diabetes
)
277,896
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Studies were performed on 10 Cape coloured non-obese
NIDDY
(non-insulin-dependent
diabetes
in the young) patients and 6 controls of similar age, sex and weight. Fasting plasma glucose, glucose assimilation rate, insulin secretion in response to an intravenous glucose tolerance test and percentage binding of radiolabelled 125I-insulin to red blood cells were assessed in all patients before and after one month of glibenclamide treatment. Both insulin secretion (P less than 0.01) and erythrocyte insulin receptor binding (P less than 0.01) were significantly reduced when compared to controls. Although glibenclamide markedly improved the second phase of insulin secretion, the intravenous glucose tolerance test stimulated the total insulin secretion to only 40% of control values. The percentage binding of 125I-insulin to red cell receptors improved considerably with therapy, and did not differ significantly from that of control values.
Diabetes
Res Clin Pract 1986 Apr
PMID:Insulin secretion and erythrocyte insulin binding in Cape coloured non-obese non-insulin-dependent diabetes in the young: effects of sulphonylurea therapy. 308 22
Diabetes mellitus
is not a single disease, but rather a syndrome comprised of a variety of diseases characterized by hyperglycaemia. Indeed it has a heterogeneous nature. Maturity Onset
Diabetes
of the Young or
MODY
is an unusual, mild type of hyperglycaemia, which develops in young women, (below the age of 25), who do not require insulin. This study describes 10 pregnancies in
MODY
women, who are compared to a group of patients with insulin-dependent
diabetes mellitus
(IDDM), a group with gestational diabetes, and a control group of normal, healthy pregnant women. Our group of pregnant
MODY
patients proved to have an intermediate form of
diabetes
, more severe than gestational diabetes and yet not as severe as insulin-dependent
diabetes mellitus
. Mean duration of
diabetes
was shorter and mean daily insulin requirement (during pregnancy) was lower among
MODY
patients in comparison to IDDM gestants. Moreover the frequency of maternal complications and Caesarean deliveries in
MODY
patients were lower than in the IDDM group, but higher when compared to the gestational diabetes group.
...
PMID:Pregnancy outcome in maturity onset diabetes at young age (MODY). 322 1
The behaviour of insulin binding receptors is rather unelucidated in non-insulin-dependent
diabetes mellitus
of the young. Authors in continuing their previous work studied the behaviour of insulin binding receptors of erythrocytes and monocytes in 9
MODY
patients. They observed that specific insulin binding of circulating blood cells was significantly decreased in all cases as compared to the controls despite of a good state of metabolism (in the case of erythrocytes 4.63 +/- 1.1% vs. 6.03 +/- 1.7%, p less than 0.05, in the case of monocytes 2.3 +/- 1.2% vs. 3.6 +/- 1.4%, p less than 0.05). The lower value of insulin binding resulted from the decrease of receptor concentrations (in the case of erythrocytes 2.36 +/- 0.78 pmol/l vs. 3.81 +/- 1.14 pmol/l, p less than 0.05).
...
PMID:Alteration of insulin-binding receptors in non-insulin dependent diabetes of the young. 340 69
The magnitude of hGH reserve was investigated in young (16-40 years old) diabetic patients. Forty patients were examined with the arginine infusion test, twenty three with a sensitized version of the L-Dopa test. The patients were divided into four groups based on the type of their illness (IDDM or
NIDDY
) and the clinical stage of IDDM. It was concluded that the hGH reserve of the various diabetic groups differs from the hGH reserve of healthy persons as well as from one another. Taking into consideration the possible causes of these differences, it is suggested that the hGH reserve depends primarily on the metabolic condition of the patients, while the type of
diabetes
(IDDM or
NIDDY
) and the insulin therapy used may also be important contributing factors. Achievement of a good metabolic control within the same type of
diabetes
leads to the normalization of the previously pathologic hGH reserve.
...
PMID:Growth hormone reserve in diabetes mellitus. 368 49
The familial aggregation and degree of adiposity of 108 Indian patients with non-insulin-dependent
diabetes
in the young was studied. All patients had onset of
diabetes
under 30 yr and the female to male ratio was 5:1. Obesity as defined was present in 52 patients (48.2%). A positive family history of
diabetes
was present in 90 patients (83.3%). Two distinct subtypes emerged in the patients with a positive family history; the offspring of conjugal diabetic parents (29%) and maturity onset
diabetes
of the young (MODY) with 3-generation transmission (13%). In conclusion, the syndrome of
NIDDY
in Indians comprises at least 3 subtypes: offspring of conjugal diabetic parents, MODY and patients without a family history (sporadic type).
Diabetes
Res 1986 Nov
PMID:The spectrum of non-insulin-dependent diabetes in the young in a migrant Indian population. 382 86
Ultrasonography was performed in three groups of young diabetics in the tropics, namely
MODY
, IDDM and tropical pancreatic
diabetes
(TPD). Several morphological abnormalities of the pancreas such as fibrosis and shrinkage of the gland, increased echogenicity and ductal dilatation were found in patients with TPD. It also helped to localize the site of calculi in the pancreas.
MODY
and IDDM patients did not show any significant changes except a slight reduction in size of the gland. Ultrasonography is a useful tool in differential diagnosis of young diabetics in tropical countries.
...
PMID:Ultrasonographic evaluation of the pancreas in tropical pancreatic diabetes. 390 32
Eight diabetics were found among 464 children, mean age 11.2 years, of 311 unselected insulin-treated mothers. By a method of age correction the total
diabetes
prevalence among the children at the age of 25 years was calculated as 3.4%. Three children were non-insulin dependent and these patients and their mothers may belong to the autosomal dominant type of
diabetes
, so-called
MODY
. In two of the other five families the fathers also had insulin-dependent
diabetes
; in two more cases first or second degree paternal relatives were insulin-dependent diabetics. Thus the prevalence of insulin-dependent
diabetes
among the children of insulin dependent mothers married to non-diabetics is calculated as 1.5% at the age of 25 years.
...
PMID:Prevalence of diabetes among children of insulin-dependent diabetic mothers. 699 10
Diabetes
is a heterogeneous disease, and its pathogenesis and etiology are still largely unknown. Recent studies have brought new knowledge showing that HLA antigens and
diabetes mellitus
are related. It has been found that the relative risk of juvenile onset
diabetes
requiring insulin treatment is greater for persons who are HLA-A1, A2, B8, BW15, BW40, CW3, DW3, DW4, DRW3 and DRW4 positive. The relative risk of the disease is additive in persons who have two of the above mentioned HLA-B alleles. Some HLA antigens (HLA-B7, DW2, DRW2, A11) are associated with a significantly lower risk of the disease and probably have a "protective" character. Maturity onset diabetes (MOD) and maturity onset
diabetes
not requiring insulin treatment (
MODY
) are not related to the HLA system. This means that MOD is completely distinct from JOD with different symptoms, course and etiopathogenesis.
...
PMID:[The HLA system and diabetes mellitus]. 722 46
Maturity-onset diabetes of the young
(
MODY
) is a model for genetic studies of non-insulin-dependent
diabetes mellitus
. We have identified 15
MODY
families in which
diabetes
is not the result of mutations in the glucokinase gene. This cohort of families will be useful for identifying other
diabetes
-susceptibility genes. Nine other candidate genes potentially implicated in insulin secretion or insulin action have been tested for linkage with
MODY
in these families, including glucokinase regulatory protein, hexokinase II, insulin receptor substrate 1, fatty acid-binding protein 2, glucagon-like peptide-1 receptor, apolipoprotein C-II, glycogen synthase, adenosine deaminase (a marker for the
MODY
gene on chromosome 20), and phosphoenolpyruvate carboxykinase. None of these loci showed evidence for linkage with
MODY
, implying that mutations in these genes do not make a major genetic contribution to the development of
MODY
. In addition to these linkage analyses, one or two affected subjects from each family were screened for the presence of the A to G mutation at nucleotide 3,243 of the mitochondrial tRNA(Leu(UUR)) gene. This mutation was not found in any of these subjects. Finally, we report the localization of the gene encoding the regulatory protein of glucokinase to chromosome 2, band p22.3 and the identification of a restriction fragment length polymorphism at this locus.
Diabetes
1994 Mar
PMID:Search for a third susceptibility gene for maturity-onset diabetes of the young. Studies with eleven candidate genes. 750 74
Non-insulin-dependent diabetes mellitus (NIDDM) is a clinically and genetically heterogeneous disorder.
Maturity-onset diabetes of the young
(
MODY
), an autosomal dominant form of NIDDM, has been used as a model for genetic studies of NIDDM. We recently reported linkage between markers on chromosome 12q and
diabetes
in 25% of our French
MODY
families. To evaluate if this gene is also implicated in late-onset NIDDM, we performed linkage studies between two markers of the
MODY
region and
diabetes
in 172 families with late-onset NIDDM. Both parametric and nonparametric methods were used in a total of 600 affected sib-pairs. Linkage was rejected in this population by all methods, implying that the
MODY
gene on chromosome 12q is not a major gene for late-onset NIDDM in this population. However, we cannot exclude a modifying role in a polygenic disorder or an important role in some families.
Diabetes
1995 Oct
PMID:Linkage analyses of the MODY3 locus on chromosome 12q with late-onset NIDDM. 755 65
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>